You are currently viewing archive.bio.org. Head to our home page to check out our fresh new look!

BIO: Senate Passage of Ebola Treatments Bill a Critical Step to Incentivize Ebola Research and Development

Dec 3 2014

...

BIO’s 2014 Pacific Rim Summit Will Highlight Growth in California’s Advanced Biofuels and Biorenewables Sector

Nov 26 2014
Executives and investors from the biofuels, specialty enzyme, renewable chemicals, algae and agriculture industries will come together at BIO’s 9th Annual Pacific Rim Summit on Industrial Biotechnology and Bioenergy on December 7-9 in San Diego  to discuss future industry growth and partnerships.  In 2013, California’s life science industry created almost $259 billion in economic activity for the state. The biorenewables sector was instrumental in generating this growth, creating high-paying jobs and attractive economic opportunities for investors.   

EPA’s Inaction on the 2014 RFS Rule Means Continued Uncertainty for Advanced Biofuel Development, BIO Says

Nov 21 2014
EPA's decision to hold the 2014 Renewable Fuel Standard (RFS) continues the atmosphere of uncertainty for the advanced biofuel industry, even while recognizing that the previously proposed methodology was flawed.

Drug Development Costs Rise Dramatically, Now Nearly $2.6 Billion per Medicine

Nov 18 2014
Washington, D.C. (November 18, 2014) – BIO issued the following statement in response to a study released today by the Tufts Center for the Study of Drug Development, which estimated the cost of developing a new prescription medicine that gains marketing approval at $2.558 billion (in 2013 dollars), including the cost of promising therapies that did not achieve FDA approval. These findings represent an increase of 145 percent, or 8.5 percent compound annual growth, since a previous study in 2003, in which Tufts estimated that cost at $1.044 billion (also in 2013 dollars).

BIO Announces Winner of the Inaugural Rosalind Franklin Award

Nov 6 2014
BIO today named Dr. Debbie Yaver, Director, Expression Technology, Genomics and Bioinformatics at Novozymes, as the recipient of the first annual Rosalind Franklin Award for leadership in industrial biotechnology.  The Rosalind Franklin Award is a newly established annual award to honor an outstanding woman in the field of industrial biotechnology and bioprocessing.  

Oregon Voters Rightly Reject Efforts to Require Mandatory Labeling of GMO Food

Nov 5 2014
With some ballots still left to be counted, it appears that Oregon voters have chosen to reject Measure 92, the state’s GMO food labeling initiative. 

BIO Statement on Maui Farming Ban Initiative

Nov 5 2014
While final results are still coming in, it appears that voters in Maui have chosen by a narrow margin to impose a ban on farming practices that will ultimately cut jobs and jeopardize the local economy and the future of agriculture in Hawaii. The measure affects agricultural practices on the islands of Maui, Molokai and Lanai.

Colorado Voters Say No to Proposition 105

Nov 5 2014
Colorado voters have decisively rejected Proposition 105, the food labeling initiative on the November 4th ballot. The measure, which would have created Colorado-only food labeling regulations for certain foods made with GMO ingredients, was defeated by a margin of 67 percent to 33 percent.

Biopharmaceutical Research and Manufacturing Sector Oppose Drug Take Back Ordinance

Oct 30 2014
BayBio, the Biotechnology Industry Organization, the Pharmaceutical Research and Manufacturers of America, the Generic Pharmaceutical Association and the Consumer Healthcare Products Association have expressed opposition to a newly introduced San Francisco drug disposal ordinance, which requires pharmaceutical companies to bear the full burden of designing, funding and operating a collection program for unused medicines in the home.

Leading Biobased Business Experts to Discuss What’s Next in Industrial Biotechnology and the Bioeconomy at the BIO 2014 Pacific Rim Summit

Oct 22 2014
During the 2014 Pacific Rim Summit Plenary Program, CEOs, CSOs and industrial biotechnology industry veterans will highlight achievements and offer insight into the quickly changing and expanding markets of renewable specialty chemical applications, biobased products, advanced biofuels and algae bioproduction.  Panelists will compare feedstock production on a global scale and discuss solutions in logistics, feedstock availability, potential for economic growth, and exploring new markets.